Coming together to take diseases apart.
How do you arrive at revolutionary treatments and breakthroughs? By unleashing a global coalition of brilliant scientific minds, fostering a collaborative process — and doing a world of good.
Overview
Every day, we collaborate at the forefront of fundamental and translational science in pursuit of groundbreaking treatment strategies for cancer, Parkinson’s and other diseases. Through shared values and an entrepreneurial spirit, we spark innovation to multiply the impact of discovery and answer critical questions about our world.
Research Areas
Learn How Our Scientists Are Making a Difference
Our scientists are hard at work investigating cancer, Parkinson's and a host of other diseases.
Departments
Where Discovery Meets Collaboration
Van Andel Institute's departments are home to exceptional scientists in the fields of epigenetics, neurodegenerative science, cell biology, metabolism and nutritional programming, and structural biology.
Faculty Directory
Meet Our Scientists
Meet Van Andel Institute’s world-class investigators, learn about their research and check out their latest findings.
Catalytic Collaborations
Collaborations
Van Andel Institute's commitment to collaboration in the U.S. and abroad creates and fuels partnerships to improve human health.
Shared Scientific Resources
Core Technologies and Services
Van Andel Institute’s Core Technologies and Services offer a comprehensive range of advanced technologies and expertise to support and enhance research at the Institute and collaborating organizations.
Business Development and Technology Transfer
Technology and Tools
Business Development and Technology Transfer supports the Institute’s mission by promoting the use of our research results and discoveries for public benefit. We remove barriers to the exchange of information and research materials so that ideas can rapidly be tested in the laboratory and translated to the clinic.
research News
Van Andel Institute to recognize Dr. J. Timothy Greenamyre with 2025 Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research
University of Minnesota, Van Andel Institute receive two-year, $5.8M grant to study Parkinson’s disease and cellular senescence
‘Sugar’ signatures help identify and classify pancreatic cancer cell subtypes
Our Impact
We're raising thousands to save millions
We’re turning hope into action for the millions of people around the world affected by diseases like cancer and Parkinson’s. Find out how you can help us make a difference.
- 122 peer-reviewed papers published in 2024, 63 of which were in high-impact journals
- 15 VAI-SU2C Epigenetics Dream Team clinical trials launched to date
- 10 clinical trials co-funded by VAI & Cure Parkinson's (out of 41 total International Linked Clinical Trials Program trials)